Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by James P. Morden
DARS: A Phase III Randomised Multicentre Study of Dysphagia- Optimised Intensity- Modulated Radiotherapy (Do-Imrt) Versus Standard Intensity- Modulated Radiotherapy (S-Imrt) in Head and Neck Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Intensity Modulated Radiotherapy (IMRT) in the Planning of Hypofractionated Treatment in Head and Neck Tumors
International Journal of Clinical Medicine
Benefits of Intensity-Modulated Radiotherapy (Imrt) in Patients With Head and Neck Malignancies- A Single Institution Experience
Journal of Evidence Based Medicine and Healthcare
Intensity-Modulated Radiotherapy (IMRT) for Syringomatous Carcinoma of the Face: A Case Report
Advances in Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiotherapy (IMRT) for Patients With Stage III Non-Small Cell Lung Cancer: First Comparative Results of Patient-Reported Outcomes (PRO)
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Treatment of Malignant Sinonasal Tumours With Intensity-Modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)
BMC Cancer
Cancer Research
Oncology
Genetics
Comparison of Intensity-Modulated Radiotherapy, Adaptive Radiotherapy, Proton Radiotherapy, and Adaptive Proton Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging
Sexual Quality of Life Following Prostate Intensity Modulated Radiotherapy (IMRT) With a Rectal/Prostate Spacer: Secondary Analysis of a Phase III Trial
Practical Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Modern External Beam Radiotherapy Techniques - Intensity Modulated Radiotherapy
Acta Physica Polonica A
Astronomy
Physics
Dysphagia and Related Toxicity in Patients With Head and Neck Cancer Receiving Helical Intensity Modulated Radiotherapy +/- Chemotherapy: Implications for Speech Pathology Management
